# Semnur Pharmaceuticals, Inc.: Form 8-K, filed Nov 20, 2023

- Company: [Semnur Pharmaceuticals, Inc.](/companies/smnr.md) (CIK 1913577)
- Form: 8-K
- Filed: 2023-11-20
- Accepted by EDGAR: Nov 20, 2023, 16:44 ET
- Period: 2023-11-17
- Accession: 0001213900-23-088773
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1913577/000121390023088773/ea188711-8k425_denalicap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1913577/000121390023088773/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1913577/000121390023088773/ea188711-8k425_denalicap.htm

Filed Nov 20, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-088773. Last ingested by Listed: Nov 4, 2026, 17:17 ET. No prices; not investment advice.